Home
electroCore

electroCore Market Share Analysis for February 2026

At electroCore, we are developing non-invasive vagus nerve stimulation (nVNS) therapy for the treatment of multiple conditions in neurology and metabolic disorders.

Health

Domainelectrocore.com

Year Founded2005

Employees51 - 200

Annual Revenue$25M - $50M

electroCore

electroCore (including company regionals)

electrocore.com

See more website traffic and engagement information

electroCore Revenue up to February 2026 is 25M - 50M

revenue generated by electroCore top domains

electroCore top domains revenue over 3 years

Revenue for electroCore top domains

electrocore.com25M - 50M

See more with Sales Intelligence

Total visits to electroCore's top domains

Understand electroCore market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

electrocore.com9.3K

See more with Sales Intelligence

Avg. visit duration in electroCore's top domains

Analyze electroCore engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

electrocore.com00:01:18

See more with Sales Intelligence

Avg. pageviews on electroCore's top domains

See how electroCore keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

electrocore.com1.68

See more with Sales Intelligence

electroCore top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by electroCore

These are the website technologies, by industry, used by electroCore top domains

Advertising (22)

Google Adsense

Email Services (7)

G Suite

Widget (5)

Twemoji

Conversion & Analytics (4)

Google Analytics

More Technologies

11

See all

News & Signals from electroCore

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewselectroCore, Inc. attended event 2025 Sleep Awards on Sep 22nd '25.ROCKAWAY, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) - electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that its Truvaga(TM) Plus handheld vagus nerve stimulation (nVNS) device has been named the "Best Relaxation Gadget" in Esquire's 2025 Sleep Awards.

NewselectroCore, Inc. acquires NeuroMetrix, Inc..electroCore completes acquisition of neurotechnology solution provider NeuroMetrix.

NewselectroCore, Inc. attended event 2025 International Brain Injury Association World Congress on Apr 17th '25.ROCKAWAY, N.J., April 17, 2025 (GLOBE NEWSWIRE) - electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that new data presented at the 2025 International Brain Injury Association World Congress highlights the effectiveness of gammaCore(R) non-invasive vagus nerve stimulation (nVNS) in treating concussive symptoms associated with mild traumatic brain injury (mTBI).